|
Originally published In Press as doi:10.1074/jbc.M107888200 on October 1, 2001
J. Biol. Chem., Vol. 276, Issue 49, 45772-45779, December 7, 2001
The Cockayne Syndrome Group B Gene Product Is Involved in General
Genome Base Excision Repair of 8-Hydroxyguanine in DNA*
Jingsheng
Tuo ,
Meltem
Müftüoglu ,
Catheryne
Chen ,
Pawel
Jaruga§,
Rebecca R.
Selzer ¶,
Robert M.
Brosh Jr. ,
Henry
Rodriguez ,
Miral
Dizdaroglu , and
Vilhelm A.
Bohr
From the Laboratory of Molecular Gerontology, NIA,
National Institutes of Health, Baltimore, Maryland 21224 and the
§ Chemical Science and Technology Laboratory, National
Institute of Standards and Technology,
Gaithersburg, Maryland 20899-8311
Received for publication, August 16, 2001, and in revised form, September 17, 2001
 |
ABSTRACT |
Cockayne Syndrome (CS) is a human genetic
disorder with two complementation groups, CS-A and CS-B. The
CSB gene product is involved in transcription-coupled
repair of DNA damage but may participate in other pathways of DNA
metabolism. The present study investigated the role of different
conserved helicase motifs of CSB in base excision
repair. Stably transformed human cell lines with site-directed
CSB mutations in different motifs within its putative
helicase domain were established. We find that CSB null and
helicase motif V and VI mutants had greater sensitivity than wild type
cells to -radiation. Whole cell extracts from CSB null and motif V/VI mutants had lower activity of 8-hydroxyguanine incision
in DNA than wild type cells. Also, 8-hydroxyguanine accumulated more in
CSB null and motif VI mutant cells than in wild type cells after exposure to -radiation. We conclude that a deficiency in general genome base excision repair of selective modified DNA base(s)
might contribute to CS pathogenesis. Furthermore, whereas the
disruption of helicase motifs V or VI results in a CSB phenotype, mutations in other helicase motifs do not cause this effect. The biological functions of CSB in different DNA repair pathways may be
mediated by distinct functional motifs of the protein.
 |
INTRODUCTION |
Cockayne Syndrome (CS)1
is an autosomal recessive human disorder with diverse clinical symptoms
that include hypersensitivity to sunlight, severe mental and physical
growth retardation, microencephaly, progressive neurological and
retinal degeneration, and skeletal abnormalities (1, 2). Genetic
analysis of fused heterodikaryons has identified two complementation
groups of CS, designated as CS-A and CS-B. The CSA and
CSB genes have been cloned, and the basic structure and
function of the genes have been characterized (3-5).
Studies using skin-originated CS-B fibroblast cells demonstrated an
increased sensitivity to UV radiation, accompanied by a delay in RNA
synthesis recovery (1, 6). The hypersensitivity of CS to UV radiation
is attributed to a pronounced defect in the repair of DNA damage
triggered by UV radiation (7). The predominant DNA damage introduced by
UV radiation is the generation of cyclobutane pyrimidine dimers and 6-4 photoproduct adducts. These lesions are bulky and helix-distorting and
can be removed by nucleotide excision repair (NER) in a
transcription-coupled repair (TCR) pathway (8-12). It is generally
believed that the inherited defects in TCR of NER constitute the
molecular basis of CS (13, 14). However, the UV sensitivity alone may
not explain the progressive neurodegeneration and other clinical
appearances in CS because short wavelength radiation like UV cannot
reach the inner organs and tissues. Thus, TCR of NER is unlikely to be
the only pathway defective in CS. There are indications that CSB also
plays a role in transcription and chromatin remodeling (9, 15).
It has been proposed that oxidative damage to DNA plays a vital role in
the development of progeroid syndromes (16). Living organisms are
constantly exposed to oxidative stress from environmental agents,
including ionizing radiation, and from endogenous metabolic processes.
A significant consequence of oxidative stress is DNA base
modifications, which can result in mutations and other types of genomic
instability. 8-Hydroxyguanine (8-OH-Gua) is one of the principal
modified bases in DNA resulting from oxidative damage, and it is
repaired mainly by the process of base excision repair (BER) (17, 18).
Although TCR is responsible for processing some types of oxidative DNA
damage in studies using CSB as a model (19-22), alternative pathways
for the function of CSB in the repair of DNA base modifications remain
to be further elucidated. This laboratory reported that whole cell
extract (WCE) from primary CSB cells incised 8-OH-dGuo at a reduced
level in comparison with normal cell lines and that this BER deficiency
in primary CS-B cells is associated with a down-regulated transcription
of the human 8-hydroxyguanine glycosylase/apurinic site lyase
(hOgg1) gene (18). This deficiency can be
complemented by transfection of the cells with the normal
CSB gene (18).
The human CSB gene encodes a protein of 1493 amino acids
with a molecular mass of 168 kDa (5, 23). By sequence homology, the
CSB gene product belongs to the SWI2/SNF2 family of
proteins. All proteins in this family contain seven putative
consecutive DNA and RNA helicase motifs (24) (see Fig. 1). In addition
to the helicase motifs, CSB contains an acidic amino acid
stretch, a glycine-rich region, and two putative nuclear localization
signal sequences (5) (see Fig. 1). Despite the presence of the
conserved motifs, CSB has not been demonstrated to possess helicase
activity as defined experimentally by an ability to unwind
double-stranded DNA in a classic strand displacement assay (25). As are
other members of the SWI/SNF subfamily, CSB is likely to be involved in
a wide variety of cellular functions, including DNA repair, transcription regulation, maintenance of chromosome stability, and
chromatin remodeling (9, 26). However, limited information is available
that addresses the functional significance of the individual motifs.
The characterization of motif II of CSB in DNA repair has been
performed by the construction of a point mutation in motif II in
hamster cells (27). The motif II mutant lost the ability to confer
cellular resistance to 4-nitroquinoline-1-oxide (4-NQO) and UV
exposure. Because motif II functions in ATP hydrolysis, the cellular
data suggested that ATP hydrolysis by CSB was essential to certain
types of DNA repair, for example the TCR of NER (27). Recent studies in
this laboratory have shown that the BER of 8-OH-Gua was deficient in
CSB null cells. However, we have found no evidence for a
function of motif II in
BER.2
To gain further understanding of the importance of CSB protein in BER,
site-specific mutations were introduced in various helicase motifs of
the CSB protein in human cells. Stably transfected CS-B cell lines with
altered CSB genes were established by transfecting plasmids
containing a site-directed CSB mutation into CS1AN cells, a
human CS-B fibroblast. The cell lines were tested for their sensitivity
to oxidative stress, the ability of whole cell extract to repair
modified DNA bases in vitro, and the accumulation of modified bases in genomic DNA after oxidative stress. We report here
that CSB plays a role in lesion-specific BER and that helicase motifs V
and VI of CSB are crucial in this function. We also find that mutations in certain motifs of CSB in human fibroblast lines lead
to the accumulation of oxidative DNA base lesions in cells that have
been exposed to oxidative stress.
 |
EXPERIMENTAL PROCEDURES |
Cell Lines and Culture Conditions--
All cell lines were
derived from CS1AN.S3.G2, a SV40-transformed human fibroblast cell line
belonging to CS complementation group B. The characteristics of the
cells have been previously described (28). The sensitivity of each cell
line to UV was tested before use. CS1AN.S3.G2 transfected with the
mammalian expression vector pcDNA3.1 alone (Invitrogen; abbreviated
as pc3.1) or pcDNA3.1 containing intact or constructed mutated
CSB gene are designated in Fig.
1. A neomycin resistance gene in the
pc3.1 plasmid was used for the selection. All cell lines were routinely grown in minimal essential medium supplemented with 15% fetal bovine
serum, 0.3 mg/ml L-glutamine, 100 units/ml penicillin, 100 µg/ml streptomycin, and 400 µg/ml geneticin (G418, Life
Technologies, Inc.).

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 1.
Structure of CSB protein and the location of
the designed mutants. The protein contains the seven conserved
helicase motifs, a highly acidic region, and two nuclear localization
signals (NLS).
|
|
Establishment of Stable Transfected Cell Lines with Site-directed
Mutations in CSB--
Site-directed mutagenesis of CSB was
performed by a uracil containing DNA based protocol (27, 29). The
plasmid pcBLsSE6 with the entire human CSB cDNA was
kindly provided by Dr. Jan Hoeijmakers. Mutations in CSB
were constructed to replace highly conserved residues in motifs Ia,
III, IV, and VI of the putative helicase domain and in the second
putative nucleotide-binding (NTB) domain. The design of most of the
constructs is presented elsewhere.3 The newly made
CSBR946A was constructed by replacing arginine with alanine using
primer 5'-CTCCATGCTGCCTCCCGGGCC-3'. After verification by
sequencing, the wild type or mutated CSB genes were cloned
into the mammalian expression vector pc3.1 and transfected into
CS1AN.S3.G2 using SuperFect Transfection Reagent (Qiagen, Santa
Clarita, CA). The cells were selected with complete medium containing
geneticin (400 µg/ml). Individual colonies were screened for
expression of the CSB transcript.
Analysis of CSB Expression in the CSB Transfectants--
The
entire CSB transcript in the transfectant clones was
verified by PCR. RNA was extracted using RNA STAT-60 (Tel-Test Inc., Friendswood, TX) followed by treatment with RNase-free DNase I (Roche
Molecular Biochemicals). cDNA was synthesized by using a reverse
transcription kit (RETROscript, Ambion, Austin, TX) with equal amounts
of total RNA (5 µg) from various cell lines according to the
manufacturer's recommendation. A high fidelity PCR master kit (Roche
Molecular Biochemicals) was used for PCR amplification of cDNA
products. The CSB (4.7 kb) cDNA was amplified as six
overlapping fragments using primers and annealing conditions as
previously described (27, 30). PCR products were detected by
electrophoresis on agarose gels with ethidium bromide staining (Fig.
2A).

View larger version (80K):
[in this window]
[in a new window]
|
Fig. 2.
Verification of CSB
transfected cell lines by RT-PCR and Western blot. A,
the RT-PCR products of mRNA of CSBR946A. The molecular weight
marker was DNA marker IV from Roche. Lane 1 is the positive
control of RT-PCR. Lanes 2-7 are the products amplified by
primers 6F/6R, 5F/5R, 4F/4R, 3F/3R, 2F/2R, and 1F/1R, respectively,
which cover different segments of the whole CSB gene.
bp, base pairs. B, CSB protein was detected with
Western blot. All mutant cell lines expressed CSB protein in a
relatively equal level to wild type. There was no detection of CSB in
WCE of CS1AN/pC3 (CSB null).
|
|
Relative quantitative RT-PCR was processed for comparing relative
transcript abundance standardized by coamplification of CSB fragment
and highly conserved fragments of 18 S rRNA from the transfected cell
lines. The RNA isolation and cDNA synthesis were as described
above. The primers 5'-GGTGTTAGGTGGCTGTGGGAATT-3' and
5'-GTATCTCGTAAGACACACATGCACAC-3' were used to produce a 671-base pair
product from CSB mRNA (27, 30). The amplification using primers for 18 S ribosomal RNA produced a 488-base pair fragment. The
linear range of PCR cycles for CSB was determined by
titrating synthesized cDNA. For PCR amplification, 0.5 unit of
AmpliTaq Gold (Applied Biosystems) was used according to the
manufacturer's procedures. In addition to standard reaction
components, PCR mixtures contained 0.2 µM of
CSB primers, 0.2 µM of 18 S RNA
primer:competimer (4:6) (QuantumRNA Classic 18S, Ambion,
Austin, TX) in a total volume of 50 µl. PCR hot start was 5 min at
80 °C, 5 min at 49 °C, 1 min at 94 °C, followed by 39 cycles
consisting of 30 s at 94 °C, 45 s at 67 °C, 1 min at
72 °C, and one final extension cycle for 7 min at 72 °C. The
ratio of CSB transcript and 18 S rRNA was determined by
running 1% agarose gels and scanning with the ImageQuant software
(Molecular Dynamics, Sunnyvale, CA).
WCEs were used to evaluate the CSB protein expression. These WCEs were
prepared as previously described (31). Equal amounts of protein (100 µg) were loaded on 3-8% polyacrylamide gels (NuPAGE) and resolved
at 200 V for 1.5 h in NuPAGE Tris-acetate SDS running buffer
(Invitrogen). The proteins were transferred onto a polyvinylidene difluoride membrane at 100 V for 1 h at 4 °C in NuPAGE transfer buffer (Invitrogen). CSB was detected with human anti-ERCC6 IgG fraction monoclonal antibody (1:1000, Austral Biologicals, San Ramon,
CA) and then hybridized with a peroxidase labeled anti-mouse IgG
antibody (1:1000). The membrane was developed with a chemiluminescent substrate (ECL+ kit, Amersham Pharmacia Biotech) and then evaluated with a Molecular Dynamics PhosphorImager.
Clonogenic Assay--
Five hundred cells were seeded in
10-cm2 dishes and allowed to attach overnight. For UV and
-radiation, cells were washed with phosphate-buffered saline and
then irradiated at the indicated doses with a UV lamp (254 nm) or with
a Gammacell 40 Exactor 137Cs -source (Nordian
International Inc., Kanata, Canada) and returned to complete medium.
For 4-NQO treatment, the cells were washed and incubated with the
indicated dose of 4-NQO in serum-free minimal medium for 30 min at
37 °C and then washed with phosphate-buffered saline and returned to
complete medium. The cells were grown for 10 days, washed once with
phosphate-buffered saline, fixed with methanol, and stained with
methylene blue for colony counting. Three independent experiments were
carried out with three parallel samples for each dose. The area under
the curve (AUC) was used as the comprehensive survival index of each
cell line and was calculated according to the trapezoid rule using
software GraphPad Prism version 3.02 (32).
Glycosylase/Apurinic Lyase Activities (Incision) on
Oligonucleotides with Modified Bases in WCE from CSB Transfected Cell
Lines--
The following oligonucleotides with a single lesion of
8-OH-Gua, 5-hydroxycytosine (5-OH-Cyt), or uracil at position 11 were employed (Midland Certified Reagent Co., Midland, TX):
5'-ATATACCGCG[8-OH-Gua]CCGGCCGATCAAGCTTAT-3', 5'-ATATACCGCG[5-OH-Cyt]CCGGCCGATCAAGCTTAT-3', and
5'-ATATACCGCG[Uracil]CCGGCCGATCAAGCTTAT-3'. All
oligonucleotides were 32P-5'-end-labeled and annealed
with the complementary strand as previously described (33). An
oligonucleotide with the same sequence as above but with a normal CG
pair at the relevant position instead of the modified nucleotide was
used as the control.
Incision reactions contained 0.15 nmol of oligonucleotide duplex, 1 µg of poly(dI-dC) competimer, 20 mM HEPES-KOH, pH
7.8, 100 mM KCl, 5 mM dithiothreitol, 5 mM EDTA, 2 mM MgCl2, and 20 µg of
WCE protein prepared as described (31). After incubation at 37 °C
for the indicated time, the reactions were terminated by the addition
of 0.8 µl of 10% SDS and 0.8 µl of 5 mg/ml proteinase K and
incubated for 10 min at 55 °C. In a 20-µl reaction mixture, DNA
precipitation was carried out by adding 4 µl of 5 mg/ml glycogen (Ambion), 8 µl of 11 M ammonia acetate, and 135 µl of
cold ethanol followed by incubation overnight at 20 °C. The
samples were centrifuged for 1 h at 4 °C followed by washing
with 500 µl of 70% ethanol. After centrifuging at 12,000 × g for 10 min, the pellet was dried and resuspended in 10 µl of formamide loading dye (5% EDTA, 0.02% bromphenol blue, 0.02%
xylene cyanol in 95% formamide), and the samples were separated by
20% denaturing polyacrylamide gel electrophoresis (containing 7 M urea, 89 mM Tris borate, pH 8.0, and 2 mM EDTA). The reaction products were visualized by
autoradiography and quantified on a PhosphorImager (Molecular Dynamics)
using ImageQuant software.
Measurement of 8-OH-Gua in Genomic DNA by Liquid
Chromatography/Mass Spectrometry--
Liquid
chromatography/isotope-dilution mass spectrometry was used to determine
the accumulation of 8-OH-Gua in genomic DNA after exposure to
-radiation. This technique measures the nucleoside form of 8-OH-Gua,
i.e. 8-hydroxy-2'-deoxyguanosine (8-OH-dGuo) (34). After
irradiation at the indicated doses in a Gammacell 40 Exactor
137Cs -source, the cells were incubated in the complete
medium at 37 °C for 30 min. Cell pellets were resuspended in lysis
buffer (0.5 M Tris, pH 8.0, 20 mM EDTA, 10 mM NaCl, 1% SDS, and 0.5 mg/ml proteinase K) and incubated
at 37 °C overnight. Nuclear DNA was isolated by the salt extraction
procedure (35, 36). The introduction of
8-hydroxy-2'-deoxyguanosine-8-18O, the digestion of DNA to
nucleosides and the optimization of liquid chromatography/mass
spectrometry parameters were performed as described (34).
Statistics--
Groups were compared by means of one-way
analysis of variance tests. Duncan's multiple range test was used for
post hoc comparison of means. Differences were considered significant
when p < 0.05.
 |
RESULTS |
Characterization of the CSB Transfected Cell Lines--
The
validity of the CSB transfected cell lines was evaluated by
sequencing and RT-PCR. All six overlapping segments of CSB were detected from cDNAs of CSB transfected cell lines
(Fig. 2A, from CSBR946A). The efficiency of CSB
expression was examined by quantitative RT-PCR. The ratios of CSB
transcript to 18 S internal standard were similar in all CSB
transfected cell lines (data not shown). Similar levels of the CSB
protein were detected by immunoblot analysis in extracts from the
CSB transfected cell lines (Fig. 2B). No band
corresponding to the CSB protein was detected in the CSB
null cell line (Fig. 2B). These data showed that the intact
CSB protein was expressed in all CSB transfected cell lines.
Because UV sensitivity is a typical characteristic of CSB
null cell lines and because we have previously reported that
CSB null cell lines are also sensitive to 4-NQO (27), all CSB transfected cell lines were tested for sensitivity to
those two agents by clonogenic assay. The typical survival curves are presented in Fig. 3. These data are from
the CSB transfected cell lines containing a point mutation
in motif VI, CSBR946A. Cells with mutations in motifs V and VI of the
putative helicase domain were unable to complement the UV and 4-NQO
sensitivity in comparison with wild type CSB. The helicase motif Ia and
III mutants demonstrated an intermediary level of UV and 4-NQO
sensitivity. The second putative NTB domain mutant showed UV and
4-NQO resistances equivalent to that of wild type CS-B cell
line.3

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 3.
Clonogenic survival after UV
(A) and 4-NQO (B) treatment of
indicated CSB transfected cell lines. The
percentage of survival after UV and 4-NQO treatments were calculated as
the fraction of the irradiated cells to the nonirradiated cells plotted
against dose. The values represent the averages, and the error
bars represent the standard deviation from at least three
independent experiments.
|
|
Sensitivity to Oxidative Stress of the Transfected CSB Cell
Lines--
The colony forming ability of CSB transfected
cell lines after -radiation is shown in Fig.
4. CSB null cells were the
most sensitive to -radiation. The AUC of CSB null cells
was 62% of that of wild type cell. CSBQ942E and CSBR946A (motif VI
mutants) were unable to complement the -radiation sensitivity of
CSB null cells. AUCs of motif VI mutants were ~68%
of that of wild type cells and were similar to that of
CSB null cells. CSBT912V and CSBT912/913V (motif V mutants)
partially complemented the -radiation sensitivity of CSB
null cells. AUCs of the motif V mutants were 84% of the wild type
cell. The motif Ia mutant, CSBP573A, the motif III mutant, CSBQ678E,
and the second putative NTB mutant, CSBK1137Q, demonstrated
-radiation resistance equivalent to that of wild type cells. A
higher dose of -radiation (3 Gy) led to larger survival differences
between wild type cells and motif VI mutants.

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 4.
Clonogenic survival after
-radiation of indicated CSB
transfected cell lines. The percentage of survival after
-radiation was calculated as the fraction of the irradiated cells to
the nonirradiated cells plotted against dose. The values represent the
averages, and the error bars represent the standard
deviation from at least three independent experiments. The AUC was
calculated by the trapezoid rule and is presented in
parentheses.
|
|
Glycosylase/Apurinic Lyase Activities (Incision) on
Oligonucleotides Containing a Single Base Modification in WCE from the
CSB Transfected Cell Lines--
The 8-OH-Gua incision activities in
WCEs from various transfected CS-B cell lines are shown in Fig.
5A, and the results from 4 independent experiments are summarized in Fig. 5B. We found reduced 8-OH-Gua incision activity in WCEs from CSB null
cells (~33% of that of CSBWT, p < 0.05), from motif
VI mutants (CSBQ942E and CSBR946A, ~50% of that of CSBWT,
p < 0.05), and from motif V mutants (CSBT912V and
CSBT912/913V, ~76% of that of CSBWT, p < 0.05). The
8-OH-Gua incision activity in WCEs from the motif Ia mutant (CSBP573A),
motif III mutant (CSBQ678E), and the second putative NTB mutant
(CSBK1137Q) were equivalent to that of wild type CSB. A time course
experiment further substantiates this difference. The relative incision
activities of 8-OH-Gua among the transfected cell lines (CSB
WT>mutants>CSB PC3.1) were similar at all time points. The time
course curves of the most 8-OH-Gua incision-deficient cell lines are
presented in Fig. 5C. Reduced 8-OH-dGuo incision in CSBQ942E
and CSB PC3.1 was observed at all time points analyzed. The largest
differences were at 3 h when the reaction was close to
saturation.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 5.
Glycosylase/apurinic lyase activities
(incision) of 8-OH-Gua in WCEs from various CSB
transfected cell lines. A, denaturing
polyacrylamide gel graph; the 29-mer band was the substrate, whereas
the 11-mer band was the product. The reaction was carried out for
3 h. B, the average of the conversion rate of 29-mer to
11-mer from four independent experiments. An asterisk
denotes a value significantly different from CSBWT (p < 0.05). C, time course of 8-OH-Gua incision activities in
WCEs from the most deficient CSB transfected cell
lines.
|
|
The in vitro 8-OH-Gua incision activities of WCEs from the
CSB transfected cell lines were then compared with their
individual in vivo -radiation survival (Fig.
6). This analysis showed a strong
correlation between the cellular resistance to radiation (AUC from the
survival curve of individual cell line) and the ability to incise
8-OH-Gua (percentage of incision). The motif contribution to 8-OH-Gua
glycosylase/apurinic lyase activities paralleled the -radiation
resistance with a good correlation (r = 0.98, p < 0.05) (Fig. 6). Thus, the defect in 8-OH-Gua
incision correlates with an increased sensitivity to -radiation.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 6.
Correlation of in vitro
8-OH-Gua incision activities of WCEs and in vivo
-radiation survival of various CSB
transfected cell lines.
|
|
To determine whether the BER defect was general or limited to the
removal of 8-OH-Gua, we assayed for the incision of two lesions
recognized by other glycosylases. There were no apparent differences
among the cell lines in incision activities of either 5-OH-Cyt or
uracil in oligonucleotide duplex (Figs.
7A and
8A). The cell lines with the
most 8-OH-Gua incision deficiency (CSBQ942E and CSBPC3.1) appeared to
have normal 5-OH-Cyt and uracil incision at all tested time points
(Figs. 7B and 8B). Incision activities of both
5-OH-Cyt and uracil were close to saturation at 60 min. Thus, the BER
deficiency in the transfected CS cell extracts appeared to be specific
for certain damage(s). Incidentally, the incision activities of
5-OH-Cyt and uracil were both higher than that of 8-OH-Gua in all WCEs.
Also, the identical level of the incision activities of 5-OH-Cyt and
uracil in various cellular extracts suggested that the cell extracts
all functioned proficiently and similarly with regards to DNA repair
incision.

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 7.
The glycosylase/apurinic lyase activities
(incision) of 5-OH-Cyt in WCEs from various CSB
transfected cell lines. A, denaturing
polyacrylamide gel graph; the 29-mer band was the substrate, whereas
the 11-mer band was the product. The reaction was carried out for 60 min. B, time course of 5-OH-Cyt incision activities in WCEs
from the most 8-OH-Gua incision-deficient CSB transfected
cell lines.
|
|

View larger version (37K):
[in this window]
[in a new window]
|
Fig. 8.
The glycosylase/apurinic lyase activities
(incision) of uracil in WCEs from various CSB
transfected cell lines. A, denaturing
polyacrylamide gel graph; the 29-mer band was the substrate, whereas
the 11-mer band was the product. The reaction was carried out for 60 min. B, time course of uracil incision activities in WCEs
from the most 8-OH-Gua incision deficient CSB transfected
cell lines.
|
|
Accumulation of 8-OH-Gua in Genomic DNA from Transfected CSB Cell
Lines after -Radiation--
Quantification of 8-OH-Gua in genomic
DNA as its nucleoside form 8-OH-dGuo was performed by liquid
chromatography/isotope-dilution mass spectrometry with selected
ion mode. Fig. 9A
illustrates the typical ion current profiles at
m/z 168 (8-OH-dGuo) and m/z 170 (8-hydroxy-2'-deoxyguanosine-8-18O). There was no
difference between the levels of 8-OH-dGuo in genomic DNA before
exposure to -radiation (0 Gy) of all tested cell lines (Fig.
9B). However, significantly greater (50-80%) levels of
8-OH-dGuo in DNA from two motif VI mutants and CSB null cells were observed 30 min after exposure to -radiation at a dose of
2 Gy (p < 0.05), thus demonstrating that 8-OH-dGuo
accumulated in these mutants relative to wild type.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 9.
Accumulation of 8-OH-dGuo in genomic DNA of
the indicated cell lines 30 min after exposure to 2 Gy of
-radiation. A, selected ion-current
profiles at m/z 168 (8-OH-dGuo) and
m/z 170 (8-OH-dGuo18O) obtained
during liquid chromatography/mass spectrometry with selected ion
monitoring analysis of an enzymatic hydrolysate of DNA.
B, the levels of 8-OH-dGuo in DNA of the indicated cell
lines. The data were from four independent experiments. An
asterisk denotes a value significantly different from CSBWT
(p < 0.05).
|
|
 |
DISCUSSION |
In the present study, human fibroblast cell lines with
site-directed mutations of the CSB gene in various motifs of
its helicase signature were generated by replacing the highly conserved
amino acids in specific motifs of CSB. The aim was to
elucidate the biological importance of the intact CSB gene
and of the specific motifs within this gene in BER. The results
demonstrate that the integrity of the CSB gene is important
for cellular resistance to -radiation. Amino acid substitutions in
helicase motifs V and VI diminished the cellular resistance to
-radiation. In the in vitro assay of BER of certain
lesions by WCE, the absence of an intact CSB gene resulted
in deficient glycosylase/apurinic lyase activity of 8-OH-Gua in DNA but
did not affect the incision of 5-OH-Cyt and uracil in DNA. Mutations in
helicase motifs V and VI of CSB resulted in reduced 8-OH-Gua
glycosylase/apurinic lyase activity. Furthermore, CSB null
or helicase motif VI mutant cells showed a higher accumulation of
8-OH-Gua in genomic DNA after exposure of the cells to
-radiation.
The resistance of the CSBWT cell line to diverse types of DNA damaging
agents that are repaired by TCR or general genome repair suggests that
this gene is involved in more pathways than TCR of active genes.
Whereas UV radiation-induced photoproducts are removed by TCR of NER,
both 4-NQO and -radiation generate modified DNA bases that are
repaired without strand bias (37, 55), e.g. the pathway of
global genome repair (38). Recently, TCR of 8-OH-Gua was observed
using an 8-OH-Gua-containing extrachromosomal plasmid model, and the
process was associated with multiple proteins (20, 21, 39).
Although the integrity of CSB is important for cell
survival, different conserved helicase motifs did not contribute
equally to the function. We have previously reported differences in the functional importance of motif II and the acidic region of
CSB in the resistances to UV and other DNA damaging agents
(40).2 We have now established seven transfected human cell
lines with mutations distributed in the four conserved helicase motifs
and in a second putative NTB domain in the C terminus of
CSB. A single or double amino acid change in the highly
conserved residues of motifs Ia, III, V, and VI abolished the function
of the CSB protein in survival, RNA synthesis recovery, and apoptosis
after UV and 4-NQO exposure.3 In contrast, a point mutation
in the putative second NTB of CSB protein showed full complementation
in its ability to repair DNA damage induced by UV light or
4-NQO.3 The pattern of resistance of different CSB mutants
to -radiation was similar to those of UV light and 4-NQO but more
deficient in motif V and VI mutants than in motif Ia and III mutants.
The in vitro deficits in 8-OH-Gua incision observed for some
mutant cell line extracts were reflected by the hypersensitivity of the
cells to -radiation and in the observed accumulation of 8-OH-Gua
lesions in the DNA of the respective cell lines. The helicase motif
contribution to 8-OH-Gua glycosylase/apurinic lyase activities
paralleled the -radiation resistance. Thus, the functional assays
support the observation that the disruption of specific helicase motifs
of CSB causes a BER defect. These results suggest that
different motifs of the CSB helicase domain may function in different
metabolic pathways.
Helicase superfamilies (SF1 and SF2) are composed of proteins that
share similar structures and participate in processes including replication, recombination, DNA repair, transcription, and chromatin assembly (41, 42). Because there has been no previous functional analysis of the putative helicase motifs I, III, IV, V, and VI in CSB,
speculation on the biochemical function of these conserved regions is
largely based on information from structural and functional studies of
other helicases.
Crystal structure of Escherichia coli Rep
helicase revealed that motif Ia acts directly with single stranded
DNA and potentially functions in the energy transduction from ATPase to
DNA (43). Mutation in motif II of eIF-4A, a RNA helicase, resulted in a large decrease in the rate of ATP hydrolysis and a loss of helicase activity (44). Biochemical characterization of PcrA helicase showed
that mutation of motif III affects ATP hydrolysis (45). Our study on
the function of motif II of CSB in human cells using a base
incision assay uncovered that this motif was not involved in BER of
8-OH-Gua and suggests that ATPase function is not essential in this
process.2 Thus, BER of 8-OH-Gua may not be an
energy-consuming process, or it may require energy from alternative
sources. This notion is supported by the data in the current work
showing that motif Ia and III mutants display normal survival after
-radiation, a treatment that causes oxidative DNA base damage.
Crystal structure analysis of motif V of E. coli Rep
helicase and of motif V of E. coli UvrB protein suggests
that this motif is involved in single-stranded DNA binding (43, 46).
E. coli UvrB and eIF-4A exhibit nucleic acid
binding defects when conserved motif VI residues are altered (44, 46).
Based on crystal structure data, helicase motif VI is not directly
involved in DNA or nucleotide binding (46, 47). However, by virtue of
its close proximity to both the NTP-binding site and the DNA-binding
site, it may act to communicate between these sites by mediating
conformational changes associated with helicase function (41). We find
that mutation in the conserved motifs V and VI of CSB caused
a severe compromise of both the in vivo and in
vitro end points examined. It was previously reported that
helicase motif V and VI of E. coli UvrB were responsible for
the enhanced catalytic activity in the presence of damaged DNA (46).
Further study on the interaction of CSB and damaged DNA with our mutant
cell lines might add more information.
Hydroxyl radical-mediated base modifications are among the most
deleterious processes induced in DNA by ionizing radiation (48, 49).
Hydroxyl radicals are produced in the hydration layer of DNA in
-radiated cells and induce the generation of 8-OH-Gua (50). To
determine whether the deficiency in BER leads to the accumulation of
8-OH-Gua in genomic DNA, the level of the nucleoside form of 8-OH-Gua,
i.e. 8-OH-dGuo in DNA was measured by liquid
chromatography/mass spectrometry after exposure of cells to a low dose
of -radiation. The results showed an enhanced level of 8-OH-dGuo in
genomic DNA after exposure of CSB null cells and two motif
VI CS-B mutants to 2 Gy of -radiation as compared with CS-B cells
transfected with the wild type CSB gene. These data demonstrate that CSB null and motif VI mutants had
compromised resistance, further supporting the conclusion that CSB
plays a role in the removal of 8-OH-Gua from DNA and the importance of motif VI in this function. Recently, Le Page et al. (20)
demonstrated that thymine glycol and 8-OH-Gua were removed by a TCR
process that did not involve NER. It was also concluded in those
studies that the repair defect in CS-B cells was due to deficient TCR alone without any defect in general genome BER (21). Our results in
CSB null and certain CSB mutants suggest a
deficiency in removal of 8-OH-Gua in the general genome BER because we
have used a DNA oligomer containing base damage in nontranscribed DNA.
This repair reflects the general genome rather than TCR. It is possible
that CSB directly interacts with other proteins involved in BER, and/or it may regulate the expression of certain BER proteins via its role as
transcriptional activator and its effect on chromatin assembly.
-Radiation introduces a variety of lesions in DNA. Many of these are
base modifications, but some are direct single- or double-stranded
breaks. At the doses that we have used here there are relatively few
single strand breaks and almost no double-stranded breaks (51).
However, we cannot exclude a contribution of the CSB protein to the
repair of strand breaks via other pathways than BER.
A basal transcription defect has been observed in human CS-B
lymphoblastoid cells and fibroblasts in the absence of exposure to DNA
damaging agents (8). A recent study showed that CSB binding to DNA
caused an alteration of the DNA conformation, a remodeling of chromatin
structure, and an interaction with core histones (52), all of which
occur during basal transcription (1, 53, 54). Thus, the CS phenotype
may arise from a combined deficiency in DNA repair and transcription.
The down-regulation of certain repair related genes in CSB
null or mutant cells could indirectly lead to the incapability of
BER.
We suggest that the biological functions of CSB in different DNA repair
pathways may be mediated by distinct functional motifs of the protein.
Our observation of increased accumulation of oxidative DNA base lesions
in DNA in CS-B cells supports the notion that these lesions accumulate
in CS patients and may contribute significantly to the phenotype of the disease.
 |
ACKNOWLEDGEMENTS |
We thank Dr. S. Nyaga and A. May for advice
and comments and Drs. Zeng, Opresko, and Souza-Pinto for helpful
discussion. Identification of certain commercial equipment or materials
does not imply recommendation or endorsement by the National Institute
of Standards and Technology, nor does it imply that the materials or
equipment identified are necessarily the best available for the purpose.
 |
FOOTNOTES |
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
Present address: Dept. of Anesthesiology and Waisman Center on
Mental Retardation and Development, University of Wisconsin, Madison,
WI 53705.
To whom correspondence should be addressed: Laboratory of
Molecular Gerontology, NIA, National Institutes of Health, 5600 Nathan
Shock Dr., Baltimore, MD 21224. Tel.: 410-558-8223; Fax: 410-558-8157; E-mail: vbohr@nih.gov.
Published, JBC Papers in Press, October 1, 2001, DOI 10.1074/jbc.M107888200
2
R. Selzer, S. Nyaga, J. Tuo, A. May, M. Muftuoglu, M. Christiansen, E. Citterio, R. M. Brosh, Jr., and V. A. Bohr, submitted for publication.
3
M. Muftuoglu, R. Selzer, J. Tuo, R. M. Robert,
Jr., and V. A. Bohr, submitted for publication.
 |
ABBREVIATIONS |
The abbreviations used are:
CS, Cockayne
syndrome;
CS-A, CS group A;
CS-B, CS group B;
BER, base excision
repair;
TCR, transcription-coupled repair;
NER, nucleotide excision
repair;
Gy, Gray;
8-OH-Gua, 8-hydroxyguanine;
8-OH-dGuo, 8-hydroxy-2'-deoxyguanosine;
5-OH-Cyt, 5-hydroxycytosine;
4-NQO, 4-nitroquinoline-1-oxide;
WCE, whole cell extract;
AUC, area under the
curve;
NTB, nucleotide-binding;
RT, reverse transcription;
PCR, polymerase chain reaction.
 |
REFERENCES |
| 1.
|
Friedberg, E. C.
(1996)
Bioessays
18,
731-738[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Nance, M. A.,
and Berry, S. A.
(1992)
Am. J. Med. Genet.
42,
68-84[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Henning, K. A.,
Li, L.,
Iyer, N.,
McDaniel, L. D.,
Reagan, M. S.,
Legerski, R.,
Schultz, R. A.,
Stefanini, M.,
Lehmann, A. R.,
and Mayne, L. V.
(1995)
Cell
82,
555-564[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Lehmann, A. R.
(1982)
Mutat. Res.
106,
347-356[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Troelstra, C.,
van Gool, A.,
de Wit, J.,
Vermeulen, W.,
Bootsma, D.,
and Hoeijmakers, J. H.
(1992)
Cell
71,
939-953[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Mayne, L. V.,
and Lehmann, A. R.
(1982)
Cancer Res.
42,
1473-1478[Abstract/Free Full Text]
|
| 7.
|
Barrett, S. F.,
Robbins, J. H.,
Tarone, R. E.,
and Kraemer, K. H.
(1991)
Mutat. Res.
255,
281-291[Medline]
[Order article via Infotrieve]
|
| 8.
|
Balajee, A. S.,
May, A.,
Dianov, G. L.,
Friedberg, E. C.,
and Bohr, V. A.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
4306-4311[Abstract/Free Full Text]
|
| 9.
|
Balajee, A. S.,
and Bohr, V. A.
(2000)
Gene (Amst.)
250,
15-30[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Evans, M. K.,
and Bohr, V. A.
(1994)
Mutat. Res.
314,
221-231[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Gunz, D.,
Hess, M. T.,
and Naegeli, H.
(1996)
J. Biol. Chem.
271,
25089-25098[Abstract/Free Full Text]
|
| 12.
|
Mellon, I.,
Bohr, V. A.,
Smith, C. A.,
and Hanawalt, P. C.
(1986)
Proc. Natl. Acad. Sci. U. S. A.
83,
8878-8882[Abstract/Free Full Text]
|
| 13.
|
van Hoffen, A.,
Natarajan, A. T.,
Mayne, L. V.,
van Zeeland, A. A.,
Mullenders, L. H.,
and Venema, J.
(1993)
Nucleic Acids Res.
21,
5890-5895[Abstract/Free Full Text]
|
| 14.
|
Venema, J.,
Mullenders, L. H.,
Natarajan, A. T.,
van Zeeland, A. A.,
and Mayne, L. V.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
4707-4711[Abstract/Free Full Text]
|
| 15.
|
Citterio, E.,
Van, D. B., V,
Schnitzler, G.,
Kanaar, R.,
Bonte, E.,
Kingston, R. E.,
Hoeijmakers, J. H.,
and Vermeulen, W.
(2000)
Mol. Cell. Biol.
20,
7643-7653[Abstract/Free Full Text]
|
| 16.
|
Kipling, D.,
and Faragher, R. G.
(1997)
Mol. Pathol.
50,
234-241[Abstract/Free Full Text]
|
| 17.
|
Dianov, G.,
Bischoff, C.,
Piotrowski, J.,
and Bohr, V. A.
(1998)
J. Biol. Chem.
273,
33811-33816[Abstract/Free Full Text]
|
| 18.
|
Dianov, G.,
Bischoff, C.,
Sunesen, M.,
and Bohr, V. A.
(1999)
Nucleic Acids Res.
27,
1365-1368[Abstract/Free Full Text]
|
| 19.
|
Cooper, P. K.,
and Leadon, S. A.
(1994)
Ann. N. Y. Acad. Sci.
726,
330-332[Medline]
[Order article via Infotrieve]
|
| 20.
|
Le Page, F.,
Klungland, A.,
Barnes, D. E.,
Sarasin, A.,
and Boiteux, S.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
8397-8402[Abstract/Free Full Text]
|
| 21.
|
Le Page, F.,
Kwoh, E. E.,
Avrutskaya, A.,
Gentil, A.,
Leadon, S. A.,
Sarasin, A.,
and Cooper, P. K.
(2000)
Cell
101,
159-171[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Leadon, S. A.,
and Cooper, P. K.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
10499-10503[Abstract/Free Full Text]
|
| 23.
|
Troelstra, C.,
Odijk, H.,
de Wit, J.,
Westerveld, A.,
Thompson, L. H.,
Bootsma, D.,
and Hoeijmakers, J. H.
(1990)
Mol. Cell. Biol.
10,
5806-5813[Abstract/Free Full Text]
|
| 24.
|
Eisen, J. A.,
Sweder, K. S.,
and Hanawalt, P. C.
(1995)
Nucleic Acids Res.
23,
2715-2723[Abstract/Free Full Text]
|
| 25.
|
Selby, C. P.,
and Sancar, A.
(1997)
J. Biol. Chem.
272,
1885-1890[Abstract/Free Full Text]
|
| 26.
|
Pazin, M. J.,
and Kadonaga, J. T.
(1997)
Cell
88,
737-740[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Brosh, R. M. J.,
Balajee, A. S.,
Selzer, R. R.,
Sunesen, M.,
De Santis, L. P.,
and Bohr, V. A.
(1999)
Mol. Biol. Cell
10,
3583-3594[Abstract/Free Full Text]
|
| 28.
|
Mayne, L. V.,
Priestley, A.,
James, M. R.,
and Burke, J. F.
(1986)
Exp. Cell Res.
162,
530-538[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Kunkel, T. A.,
Bebenek, K.,
and McClary, J.
(1991)
Methods Enzymol.
204,
125-139[Medline]
[Order article via Infotrieve]
|
| 30.
|
Mallery, D. L.,
Tanganelli, B.,
Colella, S.,
Steingrimsdottir, H.,
van Gool, A. J.,
Troelstra, C.,
Stefanini, M.,
and Lehmann, A. R.
(1998)
Am. J. Hum. Genet.
62,
77-85[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Manley, J. L.,
Fire, A.,
Samuels, M.,
and Sharp, P. A.
(1983)
Methods Enzymol.
101,
568-582[Medline]
[Order article via Infotrieve]
|
| 32.
|
Piekoszewski, W.,
and Gubala, W.
(2000)
Pol. J. Pharmacol.
52,
389-395[Medline]
[Order article via Infotrieve]
|
| 33.
|
Dianov, G.,
and Lindahl, T.
(1991)
Nucleic Acids Res.
19,
3829-3833[Abstract/Free Full Text]
|
| 34.
|
Dizdaroglu, M.,
Jaruga, P.,
and Rodriguez, H.
(2001)
Nucleic Acids Res.
29,
E12
|
| 35.
|
Balajee, A. S.,
DeSantis, L. P.,
Brosh, R. M. J.,
Selzer, R.,
and Bohr, V. A.
(2000)
Oncogene
19,
477-489[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Miller, S. A.,
Dykes, D. D.,
and Polesky, H. F.
(1988)
Nucleic Acids Res.
16,
1215[Free Full Text]
|
| 37.
|
Snyderwine, E. G.,
and Bohr, V. A.
(1992)
Cancer Res.
52,
4183-4189[Abstract/Free Full Text]
|
| 38.
|
van Oosterwijk, M. F.,
Versteeg, A.,
Filon, R.,
van Zeeland, A. A.,
and Mullenders, L. H.
(1996)
Mol. Cell. Biol.
16,
4436-4444[Abstract]
|
| 39.
|
Cooper, P. K.,
Nouspikel, T.,
Clarkson, S. G.,
and Leadon, S. A.
(1997)
Science
275,
990-993[Abstract/Free Full Text]
|
| 40.
|
Sunesen, M.,
Selzer, R. R.,
Brosh, R. M.,
Balajee, A. S.,
Stevnsner, T.,
and Bohr, V. A.
(2000)
Nucleic Acids Res.
28,
3151-3159[Abstract/Free Full Text]
|
| 41.
|
Hall, M. C.,
and Matson, S. W.
(1999)
Mol. Microbiol.
34,
867-877[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Gorbalenya, A. E.,
Koonin, E. V.,
Donchenko, A. P.,
and Blinov, V. M.
(1989)
Nucleic Acids Res.
17,
4713-4730[Abstract/Free Full Text]
|
| 43.
|
Korolev, S.,
Hsieh, J.,
Gauss, G. H.,
Lohman, T. M.,
and Waksman, G.
(1997)
Cell
90,
635-647[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Pause, A.,
and Sonenberg, N.
(1992)
EMBO J.
11,
2643-2654[Medline]
[Order article via Infotrieve]
|
| 45.
|
Dillingham, M. S.,
Soultanas, P.,
and Wigley, D. B.
(1999)
Nucleic Acids Res.
27,
3310-3317[Abstract/Free Full Text]
|
| 46.
|
Moolenaar, G. F.,
Visse, R.,
Ortiz-Buysse, M.,
Goosen, N.,
and Van de Putte, P.
(1994)
J. Mol. Biol.
240,
294-307[CrossRef][Medline]
[Order article via Infotrieve]
|
| 47.
|
Yao, N.,
Hesson, T.,
Cable, M.,
Hong, Z.,
Kwong, A. D.,
Le, H. V.,
and Weber, P. C.
(1997)
Nat. Struct. Biol.
4,
463-467[CrossRef][Medline]
[Order article via Infotrieve]
|
| 48.
|
Dizdaroglu, M.
(1985)
Biochemistry
24,
4476-4481[CrossRef][Medline]
[Order article via Infotrieve]
|
| 49.
|
Douki, T.,
Martini, R.,
Ravanat, J. L.,
Turesky, R. J.,
and Cadet, J.
(1997)
Carcinogenesis
18,
2385-2391[Abstract/Free Full Text]
|
| 50.
|
Ohshima, H.,
Iida, Y.,
Matsuda, A.,
and Kuwabara, M.
(1996)
J. Radiat. Res. (Tokyo)
37,
199-207[Medline]
[Order article via Infotrieve]
|
| 51.
|
Tabocchini, M. A.,
Rothkamm, K.,
Signoretti, C.,
Risse, J.,
Sapora, O.,
and Lobrich, M.
(2000)
Mutat. Res.
461,
71-82[Medline]
[Order article via Infotrieve]
|
| 52.
|
Citterio, E.,
Vermeulen, W.,
and Hoeijmakers, J. H.
(2000)
Cell
101,
447-450[CrossRef][Medline]
[Order article via Infotrieve]
|
| 53.
|
Friedberg, E. C.
(1996)
Annu. Rev. Biochem.
65,
15-42[CrossRef][Medline]
[Order article via Infotrieve]
|
| 54.
|
van Gool, A. J.,
Citterio, E.,
Rademakers, S.,
van Os, R.,
Vermeulen, W.,
Constantinou, A.,
Egly, J. M.,
Bootsma, D.,
and Hoeijmakers, J. H.
(1997)
EMBO J.
16,
5955-5965[CrossRef][Medline]
[Order article via Infotrieve]
|
| 55.
|
May, A.,
and Bohr, V. A.
(2000)
B. B. R. C.
269,
433-437
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Muftuoglu, N. C. de Souza-Pinto, A. Dogan, M. Aamann, T. Stevnsner, I. Rybanska, G. Kirkali, M. Dizdaroglu, and V. A. Bohr
Cockayne Syndrome Group B Protein Stimulates Repair of Formamidopyrimidines by NEIL1 DNA Glycosylase
J. Biol. Chem.,
April 3, 2009;
284(14):
9270 - 9279.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Maynard, A. M. Swistowska, J. W. Lee, Y. Liu, S.-T. Liu, A. B. Da Cruz, M. Rao, N. C. de Souza-Pinto, X. Zeng, and V. A. Bohr
Human Embryonic Stem Cells Have Enhanced Repair of Multiple Forms of DNA Damage
Stem Cells,
September 1, 2008;
26(9):
2266 - 2274.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C F Arlett, M H L Green, P B Rogers, A R Lehmann, and P N Plowman
Minimal ionizing radiation sensitivity in a large cohort of xeroderma pigmentosum fibroblasts
Br. J. Radiol.,
January 1, 2008;
81(961):
51 - 58.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Pastoriza-Gallego, J. Armier, and A. Sarasin
Transcription through 8-oxoguanine in DNA repair-proficient and Csb /Ogg1 DNA repair-deficient mouse embryonic fibroblasts is dependent upon promoter strength and sequence context
Mutagenesis,
September 1, 2007;
22(5):
343 - 351.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Z. Imam, F. E. Indig, W.-H. Cheng, S. P. Saxena, T. Stevnsner, D. Kufe, and V. A. Bohr
Cockayne syndrome protein B interacts with and is phosphorylated by c-Abl tyrosine kinase
Nucleic Acids Res.,
August 1, 2007;
35(15):
4941 - 4951.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-K. Wong, M. Muftuoglu, G. Beck, S. Z. Imam, V. A. Bohr, and D. M. Wilson III
Cockayne syndrome B protein stimulates apurinic endonuclease 1 activity and protects against agents that introduce base excision repair intermediates
Nucleic Acids Res.,
June 12, 2007;
(2007)
gkm404v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. M. Kooter, J. L. A. Pennings, P. H. B. Fokkens, D. L. A. C. Leseman, A. J. F. Boere, M. E. Gerlofs-Nijland, F. R. Cassee, J. A. C. Schalk, T. J. H. Orzechowski, M. M. Schaap, et al.
Ozone induces clear cellular and molecular responses in the mouse lung independently of the transcription-coupled repair status
J Appl Physiol,
March 1, 2007;
102(3):
1185 - 1192.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Tuo, B. Ning, C. M. Bojanowski, Z.-N. Lin, R. J. Ross, G. F. Reed, D. Shen, X. Jiao, M. Zhou, E. Y. Chew, et al.
Synergic effect of polymorphisms in ERCC6 5' flanking region and complement factor H on age-related macular degeneration predisposition
PNAS,
June 13, 2006;
103(24):
9256 - 9261.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Thorslund, C. von Kobbe, J. A. Harrigan, F. E. Indig, M. Christiansen, T. Stevnsner, and V. A. Bohr
Cooperation of the Cockayne Syndrome Group B Protein and Poly(ADP-Ribose) Polymerase 1 in the Response to Oxidative Stress
Mol. Cell. Biol.,
September 1, 2005;
25(17):
7625 - 7636.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Liu, B. Xu, T. A. Cavalieri, and C. E. Hock
Attenuation of antioxidative capacity enhances reperfusion injury in aged rat myocardium after MI/R
Am J Physiol Heart Circ Physiol,
December 1, 2004;
287(6):
H2719 - H2727.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Horibata, Y. Iwamoto, I. Kuraoka, N. G. J. Jaspers, A. Kurimasa, M. Oshimura, M. Ichihashi, and K. Tanaka
From The Cover: Complete absence of Cockayne syndrome group B gene product gives rise to UV-sensitive syndrome but not Cockayne syndrome
PNAS,
October 26, 2004;
101(43):
15410 - 15415.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. de Waard, J. de Wit, J.-O. Andressoo, C. T. M. van Oostrom, B. Riis, A. Weimann, H. E. Poulsen, H. van Steeg, J. H. J. Hoeijmakers, and G. T. J. van der Horst
Different Effects of CSA and CSB Deficiency on Sensitivity to Oxidative DNA Damage
Mol. Cell. Biol.,
September 15, 2004;
24(18):
7941 - 7948.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Tuo, N. Tuaillon, D. Shen, and C.-C. Chan
Endotoxin-Induced Uveitis in Cyclooxygenase-2-Deficient Mice
Invest. Ophthalmol. Vis. Sci.,
July 1, 2004;
45(7):
2306 - 2313.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. L. Peterson and J. Cote
Cellular machineries for chromosomal DNA repair
Genes & Dev.,
March 15, 2004;
18(6):
602 - 616.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Cheadle and J. R. Sampson
Exposing the MYtH about base excision repair and human inherited disease
Hum. Mol. Genet.,
October 15, 2003;
12(90002):
R159 - 165.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Flohr, A. Burkle, J. P. Radicella, and B. Epe
Poly(ADP-ribosyl)ation accelerates DNA repair in a pathway dependent on Cockayne syndrome B protein
Nucleic Acids Res.,
September 15, 2003;
31(18):
5332 - 5337.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Shirkey, N. J. McMaster, S. C. Smith, D. J. Wright, H. Rodriguez, P. Jaruga, M. Birincioglu, R. F. Helm, and M. Potts
Genomic DNA of Nostoc commune (Cyanobacteria) becomes covalently modified during long-term (decades) desiccation but is protected from oxidative damage and degradation
Nucleic Acids Res.,
June 15, 2003;
31(12):
2995 - 3005.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. TUO, P. JARUGA, H. RODRIGUEZ, V. A. BOHR, and M. DIZDAROGLU
Primary fibroblasts of Cockayne syndrome patients are defective in cellular repair of 8-hydroxyguanine and 8-hydroxyadenine resulting from oxidative stress
FASEB J,
April 1, 2003;
17(6):
668 - 674.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Christiansen, T. Stevnsner, C. Modin, P. M. Martensen, R. M. Brosh Jr, and V. A. Bohr
Functional consequences of mutations in the conserved SF2 motifs and post-translational phosphorylation of the CSB protein
Nucleic Acids Res.,
February 1, 2003;
31(3):
963 - 973.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. R. Parker, R. N. O'Meally, D. H. Oliver, L. Hua, W. G. Nelson, T. L. DeWeese, and J. R. Eshleman
8-Hydroxyguanosine Repair Is Defective in Some Microsatellite Stable Colorectal Cancer Cells
Cancer Res.,
December 15, 2002;
62(24):
7230 - 7233.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Tuo, P. Jaruga, H. Rodriguez, M. Dizdaroglu, and V. A. Bohr
The Cockayne Syndrome Group B Gene Product Is Involved in Cellular Repair of 8-Hydroxyadenine in DNA
J. Biol. Chem.,
August 16, 2002;
277(34):
30832 - 30837.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|